Tag: NASDAQ:MIRM

Analysts Viewpoint

Mirum Pharmaceuticals Inc’s filing revealed that its CHIEF FINANCIAL OFFICER BJERKHOLT ERIC acquired Company’s shares for reported $49600.0 on Mar

Stock Earnings

In a filing, Mirum Pharmaceuticals Inc revealed its CHIEF FINANCIAL OFFICER BJERKHOLT ERIC acquired Company’s shares for reported $49600.0 on

Analysts Viewpoint

Mirum Pharmaceuticals Inc’s recent filing unveils that its CHIEF FINANCIAL OFFICER BJERKHOLT ERIC acquired Company’s shares for reported $49600.0 on